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Infections in Children Aged 3 Months to 2 YearsPediatric urinary tract infections (UTIs) include a range of
asymptomatic bacteriuria, lower UTIs (i.e., cystitis), acute
pyelonephritis, acute lobar nephronia, and severe renal
abscess formation. If not properly treated, pediatric UTIs
can result in renal scar formation and subsequently, a
deterioration of renal function. Hence, pediatric UTIs have
attracted wide attention, both from the clinical and general
viewpoints.1,2 To provide a clinically consistent and cost-
effective practice for the diagnosis, treatment, and
further management of pediatric UTIs, the British National
Institute for Health and Clinical Excellence, has issued
guidance on these matters.3 In a similar manner, the Amer-
ican Academy of Pediatrics (AAP), revised its clinical prac-
tice guidelines in 2011 for the initial diagnosis, treatment,
and management of UTIs in febrile infants and children aged
2e24 months.4 The new AAP guidelines addressed the evi-
dence provided by various additional studies published after
the initial guidelines, which were issued in 1999.
In this study, Wang et al5 attempted to determine if
there were further indications from the physical examina-
tion and personal history to aid pediatric UTI diagnosis.
They performed a urine culture for pediatric patients aged
3e24 months, with a tympanic temperature > 38C and a
urinalysis (UA), revealing either leukocyte count  5/high-
power field or a positive urine dipstick result for leukocyte
esterase and nitrite. This UA approach, named the “urine
culture standard” by Wang et al,5 could lead to a high
sensitivity at the expense of specificity, for the diagnosis of
UTIs, as indicated in the 2011 AAP guidelines.4 The final
diagnosis of UTIs in their study was based on a positive urine
culture, similar to that suggested in the 2011 AAP guide-
lines, in which both a positive UA result (pyuria and/or
bacteriuria) and the presence of at least 50,000 colony-
forming units (CFU)/mL of a uropathogen were required
to establish a diagnosis of UTI.
The 2011 AAP guidelines also provided individual risk
factors to assist clinicians in further assessing the likelihood
of pediatric UTIs.4 The risk factors for UTIs in girls were as
follows: white race, age < 12 months, temperature > 39C,
fever  2 days, and the absence of another source of
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race, temperature > 39C, fever > 1 day, the absence of
another source of infection, and much more importantly,
uncircumcision. In this study, Wang et al5 extended the an-
alyses of the aforementioned risk factors to findings identi-
fied during the physical examination of pediatric cases with
suspicious febrile UTIs. The authors concluded that if a
febrile pediatric patient aged 3e24 months was female, <1
year old, with no throat infection, and a reduced appetite,
then the patient was more likely to have a UTI.5 This finding
highlights the importance of a clinical physical examination
in identifying pediatric UTIs. Nevertheless, a larger cohort
study, includingmore cases of pediatric UTIs, is warranted to
verify the risk factors identified in this investigation.
When initiating antibiotic treatment, physicians should
consider the regional antimicrobial susceptibility before
antibiotic sensitivity results become available for isolated
uropathogens. The antibiotics should be administered by
oral and/or parenteral route for a duration of 7e14 days.
Nevertheless, a longer duration of 3 weeks of antibiotic
therapy may be needed for pediatric patients with a severe
renal infection such as acute lobar nephronia.6 Antimicro-
bial prophylaxis has commonly been suggested for UTI pa-
tients diagnosed with vesicoureteral reflux (VUR), assuming
that a patient with VUR is more likely to encounter recur-
rent UTIs and subsequently develop renal scar formation.
Recently, a well-designed study, the Randomized Inter-
vention for Children with Vesicoureteral Reflux (RIVUR),
concluded that antimicrobial prophylaxis was associated
with a substantially reduced risk of recurrence of UTI but
not of renal scarring.7 The reduced risk of recurrent UTIs
was not associated with a lower probability of renal scar
formation. This may be attributable to UTIs in this study
being diagnosed early and treated promptly, thus pre-
venting subsequent renal damage.
In brief, the clinical spectrum of pediatric UTIs varies
widely, and the correct, timely diagnosis and treatment are
warranted to reduce the severity of UTIs, as well as sub-
sequent renal scar formation. Henceforth, further studies,
either in clinical settings or in research laboratories, areby Elsevier Taiwan LLC. This is an open access article under the
/4.0/).
262 Editorialwarranted to elucidate the interactions between uropath-
ogens and pediatric host factors, as well as to clarify the
roles of different urinary anatomical factors, such as VUR,
in the pathogenesis of pediatric UTIs.
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